Literature DB >> 20195808

Revision hip arthroplasty: infection is the most common cause of failure.

S Mehdi Jafari1, Catelyn Coyle, S M Javad Mortazavi, Peter F Sharkey, Javad Parvizi.   

Abstract

BACKGROUND: Revision total hip arthroplasty (THA), although relieving pain and restoring function, fails in some patients. In contrast to failures in primary THA, the frequency of the causes of failure in revision THA has been less well established. QUESTIONS/PURPOSES: We therefore determined the rate of each failure mode and the survivorship of revision THAs.
METHODS: We retrospectively reviewed the charts of 1366 revision THAs performed between 2000 and 2007. There were 609 (44.5%) men and 757 (55.5%) women with a mean age of 66 years. The indications for the revision surgery were mainly aseptic loosening (51%), instability (15%), wear (14%), and infection (8%). The minimum followup was 1 day (mean, 5.5 years; range, 1 day to 9 years).
RESULTS: Two hundred fifty-six of the revisions (18.7%) failed with an average time to failure of 16.6 months (range, 1 day to 7.5 years). Among 256 failed hips, infection was the most common cause of failure (30.2%) followed by instability (25.1%) and aseptic loosening (19.4%). At 5 years, the survivorships of septic and aseptic groups were 67% and 84.8%, respectively. Revision for infection or instability appears to have a considerably lower survivorship when compared to revision for aseptic causes.
CONCLUSIONS: The lower survivorship of revision for infection or instability highlights the importance of implementing better preventative methods that can minimize the impact of these two major causes of failure. LEVEL OF EVIDENCE: Level III, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2010        PMID: 20195808      PMCID: PMC2895846          DOI: 10.1007/s11999-010-1251-6

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Revision total hip arthroplasty: hospital cost and reimbursement analysis.

Authors:  John F Crowe; Thomas P Sculco; Barbara Kahn
Journal:  Clin Orthop Relat Res       Date:  2003-08       Impact factor: 4.176

2.  Failure rates for 4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register.

Authors:  S A Lie; L I Havelin; O N Furnes; L B Engesaeter; S E Vollset
Journal:  J Bone Joint Surg Br       Date:  2004-05

3.  The epidemiology of revision total hip arthroplasty in the United States.

Authors:  Kevin J Bozic; Steven M Kurtz; Edmund Lau; Kevin Ong; Thomas P Vail; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2009-01       Impact factor: 5.284

4.  Cost analysis of revision total hip arthroplasty. A 5-year followup study.

Authors:  R L Barrack; J Sawhney; J Hsu; R H Cofield
Journal:  Clin Orthop Relat Res       Date:  1999-12       Impact factor: 4.176

5.  Survivorship analysis in the evaluation of joint replacement.

Authors:  F Dorey; H C Amstutz
Journal:  J Arthroplasty       Date:  1986       Impact factor: 4.757

6.  Economics of revision total hip arthroplasty.

Authors:  R L Barrack
Journal:  Clin Orthop Relat Res       Date:  1995-10       Impact factor: 4.176

7.  Cost awareness and cost containment at the Hospital for Special Surgery. Strategies and total hip replacement cost centers.

Authors:  D B Levine; B J Cole; S A Rodeo
Journal:  Clin Orthop Relat Res       Date:  1995-02       Impact factor: 4.176

8.  Surgeon work input and risk in primary versus revision total joint arthroplasty.

Authors:  R L Barrack; G J Hoffman; W V Tejeiro; L J Carpenter
Journal:  J Arthroplasty       Date:  1995-06       Impact factor: 4.757

9.  Revision and primary hip and knee arthroplasty. A cost analysis.

Authors:  C J Lavernia; M K Drakeford; A K Tsao; A Gittelsohn; K A Krackow; D S Hungerford
Journal:  Clin Orthop Relat Res       Date:  1995-02       Impact factor: 4.176

10.  Revision total joint arthroplasty: does medicare reimbursement justify time spent?

Authors:  M A Ritter; K D Carr; E M Keating; P N Faris; D L Bankoff; P M Ireland
Journal:  Orthopedics       Date:  1996-02       Impact factor: 1.390

View more
  50 in total

1.  Mechanical, in vitro antimicrobial, and biological properties of plasma-sprayed silver-doped hydroxyapatite coating.

Authors:  Mangal Roy; Gary A Fielding; Haluk Beyenal; Amit Bandyopadhyay; Susmita Bose
Journal:  ACS Appl Mater Interfaces       Date:  2012-02-28       Impact factor: 9.229

2.  Efficacy of revision surgery for the dislocating total hip arthroplasty: report from a large community registry.

Authors:  Tiare Salassa; Daniel Hoeffel; Susan Mehle; Penny Tatman; Terence J Gioe
Journal:  Clin Orthop Relat Res       Date:  2013-10-23       Impact factor: 4.176

3.  [Painful hip arthroplasty: a diagnostic algorithm].

Authors:  M Hoberg; B M Holzapfel; M Rudert
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

4.  CORR Insights®: Are Patients Who Undergo THA for Infection at Higher Risk for 30-day Complications?

Authors:  Charalampos G Zalavras
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

Review 5.  A systematic review of the causes of failure of Revision Total Hip Arthroplasty.

Authors:  Connor Kenney; Steven Dick; Justin Lea; Jiayong Liu; Nabil A Ebraheim
Journal:  J Orthop       Date:  2019-05-02

6.  Onlay fibula autografting technique and its comparison with cortical allograft for the reconstruction of periprosthetic bone defects around the femur.

Authors:  İbrahim Tuncay; Remzi Tözün; Orkhan Aliyev; Göksel Dikmen; Gökçer Uzer; Vahit Emre Özden; Fatih Yıldız
Journal:  Int Orthop       Date:  2020-11-18       Impact factor: 3.075

7.  CORR Insights®: Tantalum Components in Difficult Acetabular Revisions Have Good Survival at 5 to 10 Years: Longer Term Followup of a Previous Report.

Authors:  Rocco P Pitto
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

8.  Diagnosis of the failed total hip replacement.

Authors:  Adeel Aqil; Nikhil Shah
Journal:  J Clin Orthop Trauma       Date:  2019-12-03

9.  In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.

Authors:  Alexandra I Stavrakis; Suwei Zhu; Vishal Hegde; Amanda H Loftin; Alyssa G Ashbaugh; Jared A Niska; Lloyd S Miller; Tatiana Segura; Nicholas M Bernthal
Journal:  J Bone Joint Surg Am       Date:  2016-07-20       Impact factor: 5.284

10.  Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up.

Authors:  Baochao Ji; Boyong Xu; Wentao Guo; Aili Rehei; Wenbo Mu; Desheng Yang; Li Cao
Journal:  Int Orthop       Date:  2016-09-20       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.